The group studies redox-active proteins in humans and mycobacteria. The main subject of research is enzymes of the cytochrome P450 (CYP) family, their redox partners and activity modulators.

 In humans, CYPs metabolize both endogenous compounds and drugs. Some CYPs are targets for the action of medicinal compounds, since they catalyze important reactions in the biosynthesis of cholesterol, vitamin D3, eicosanoids and steroid hormones that affect human health and sexual development. At the same time, the functions of most CYP mycobacteria, and, in particular, Mycobacterium tuberculosis, are unknown. Complex structural and functional studies are an integral part of the search for natural and alternative substrates, as well as selective inhibitors of CYP enzymes.